"Die ISA führt Arzneimittelstudien durch, um Patienten – fachärztlich begleitet – innovative Therapien mit modernen Wirkstoffen bieten zu können. Dabei arbeitet die ISA mit führenden pharmazeutischen Unternehmen und Forschungsinstituten und trägt dazu bei, dass fortschrittliche Behandlungsverfahren und Medikamente weiter entwickelt werden."

During the past decade, ISA - Interdisciplinary Study Association GmbH conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 18 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 16 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ISA - Interdisciplinary Study Association GmbH" #1 sponsor was "Janssen Research & Development, LLC" with 8 trials, followed by "Pfizer" with 8 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored, "UNION therapeutics" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ISA - Interdisciplinary Study Association GmbH" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "ISA - Interdisciplinary Study Association GmbH" are "Atopic Dermatitis" (8 trials), "Psoriasis" (8 trials), "Dermatitis, Atopic" (4 trials), "Arthritis, Psoriatic" (3 trials) and "Plaque Psoriasis" (3 trials). Many other conditions were trialed in "ISA - Interdisciplinary Study Association GmbH" in a lesser frequency.

Most popular intervention types in "ISA - Interdisciplinary Study Association GmbH" are "Drug" (26 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Guselkumab" (6 trials), "Baricitinib" (2 trials), "Etanercept" (2 trials) and "JNJ-77242113" (2 trials). Other intervention names were less common.

The vast majority of trials in "ISA - Interdisciplinary Study Association GmbH" are 28 trials for "All" genders.

Currently, there are NaN active trials in "ISA - Interdisciplinary Study Association GmbH". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in ISA - Interdisciplinary Study Association GmbH, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in ISA - Interdisciplinary Study Association GmbH, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".